OVERVIEW: The Lilly Foundation regularly funds projects in developing countries that are geared toward health and disease prevention/treatment.
IP TAKE: Nonprofits working on disease prevention in the developing world should keep this funder in mind when looking for project sponsors. Lilly considers grant applications from past grantees. First-timers, however, would be wise to form a relationship with the organization before outlining their project proposals.
PROFILE: Eli Lilly and Company is among the largest pharmaceutical companies in the world. Its charitable arm, Lilly Foundation, was established in 1968, and remains separate from the Lilly Endowment. In the global health field, the foundation seeks to improve "the lives of people who lack the resources to obtain quality health care, with a primary focus on low and middle-income countries." Its funding priorities include combating tuberculosis, particularly strains that resist commonly available pharmaceutical treatments; and providing hunger relief in the developing world. Stated priorities aside, the Lilly Foundation regularly funds projects in developing countries that are geared toward health and disease prevention/treatment more generally.
Lilly does not fund many international programs, but both large and small organizations are welcome to apply. When it does fund INGOs, the foundation tends to give them larger health grants. Grants typically range from around $25,000 to $250,000.
Lilly does not accept unsolicited proposals from groups with which it has not collaborated in the past. It prefers to initiate and develop its own partnerships with grantees that have a proven expertise in Lilly's program areas.